Olympus Corp
+11.1%

Healthcare & biotech / Medical and optical products

🚀 Founded 1919 🌎 Japan 🏷️ OCPNY JP3201200007 ⭐ 10000

ℹ️ Info

🧾 At a Glance 📎 Core Facts 🛍️ Products/Services ⭐ Ratings 🧑‍💼 Executives 💬 My Comments

💡 Analytics

🔔 Insights (2) 🏢 Company Q&A (465) 🛠️ Industry Q&A (98) 🏁 Competitors 📊 Price Low 📈 Price Swings ⚡ SWOT 🏛️ PEST 🌀 Porter's Five Forces ✨ Score Positive ⚠️ Risk Assessment 🧩 Segmentation 🅶 Google Links

💸 Financials

⚖️ Balance Sheet 💵 Income Statement 🔄 Cash Flow 👑 Owner Earnings

📊 Ratios

💰 Margins 📐 Financial Ratios 🌱 Growth 📏 Enterprise Value 📌 Key Metrics 💵 Dividends

🔧 Tools

✅ Due Diligence

📚 Resources

📰 News 🔶 Clusters 🗂️ SEC Filings 🔢 Stock Split History 📢 Press Releases 👤 Insider Trades 📅 Earnings Calendar 🌐 Web 📝 Reports

🔥 Video Insights

[Disclaimer]

Olympus Corp: Why the Stock Is Falling and What You Should Know

August 31, 2025

This video explains the recent decline of Olympus Corporation’s stock, reviews the company’s financial performance, risks, dividends, and long-term potential for investors. Learn more on InsightfulValue.com.

Why Is Olympus Corp’s Stock Price Taking a Hit? A Deep Dive with InsightfulValue

June 26, 2025

In this video, we explore why Olympus Corporation’s stock price has declined recently. We cover the company’s business model, financial performance, dividend trends, and the risks and opportunities investors should consider. This review aims to provide clear, jargon-free insights for those interested in medical technology investments. Subscribe for more value-focused company reviews from InsightfulValue.

What is special about us?

Newsletter

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

To start evaluating the companies of your choice, sign up or log in.